Thunder Biotech Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.1M

  • Investors
  • 1

Thunder Biotech General Information

Description

Developer of macrophage-based cancer immunotherapies designed to target solid tumors. The company's cell therapies genetically engineer patients' macrophages with chimeric antigen receptors to recognize specific tumor biomarkers and attack cancer cells, enabling cancer patients with solid tumors to access targeted immunotherapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 395 Cougar Boulevard
  • Suite 103, Sorenson Legacy Tower
  • Provo, UT 84604
  • United States
+1 (801)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 395 Cougar Boulevard
  • Suite 103, Sorenson Legacy Tower
  • Provo, UT 84604
  • United States
+1 (801)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thunder Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 23-Feb-2024 $1.1M Completed Pre-Clinical Trials
4. Later Stage VC 11-Oct-2022 Completed Pre-Clinical Trials
3. Later Stage VC 01-May-2021 Completed Pre-Clinical Trials
2. Early Stage VC 31-Jul-2020 $10M $12M Completed Pre-Clinical Trials
1. Seed Round 01-Jul-2017 $2M $2M Completed Pre-Clinical Trials
To view Thunder Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Thunder Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of macrophage-based cancer immunotherapies designed to target solid tumors. The company's cell therapies genet
Drug Discovery
Provo, UT
18 As of 2024

Cambridge, MA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thunder Biotech Competitors (3)

One of Thunder Biotech’s 3 competitors is Create Medicines, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Create Medicines Venture Capital-Backed Cambridge, MA
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Inceptor Bio Venture Capital-Backed Morrisville, NC
You’re viewing 3 of 3 competitors. Get the full list »

Thunder Biotech Patents

Thunder Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250082679-A1 Method of targeting cells and associated compositions Pending 24-Jun-2021
WO-2022272088-A1 Method of targeting cells and associated compositions Inactive 24-Jun-2021
US-20210052643-A1 Modified macrophages and macrophage precursors and associated methods Inactive 05-Jan-2018
WO-2019135879-A1 Modified macrophages and macrophage precursors and associated methods Inactive 05-Jan-2018
AU-2017414703-A1 Transgenic macrophages, chimeric antigen receptors, and associated methods Active 17-May-2017 C07K16/40
To view Thunder Biotech’s complete patent history, request access »

Thunder Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thunder Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Trich Ventures Venture Capital Minority
To view Thunder Biotech’s complete investors history, request access »

Thunder Biotech FAQs

  • When was Thunder Biotech founded?

    Thunder Biotech was founded in 2016.

  • Where is Thunder Biotech headquartered?

    Thunder Biotech is headquartered in Provo, UT.

  • What is the size of Thunder Biotech?

    Thunder Biotech has 18 total employees.

  • What industry is Thunder Biotech in?

    Thunder Biotech’s primary industry is Drug Discovery.

  • Is Thunder Biotech a private or public company?

    Thunder Biotech is a Private company.

  • What is Thunder Biotech’s current revenue?

    The current revenue for Thunder Biotech is .

  • How much funding has Thunder Biotech raised over time?

    Thunder Biotech has raised $65.4M.

  • Who are Thunder Biotech’s investors?

    Trich Ventures has invested in Thunder Biotech.

  • Who are Thunder Biotech’s competitors?

    Create Medicines, Carisma Therapeutics, and Inceptor Bio are competitors of Thunder Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process